Skip to main content
. 2016 Jul 22;12(3):2092–2098. doi: 10.3892/ol.2016.4906

Figure 1.

Figure 1.

Staining of tissue samples. Left column, positive control (mammacarcinoma tissue); right column, endometrial adenocarcinoma tissue; upper row, LHCGR-staining; lower row, VEGFR2-staining. Magnification, ×10. VEGFR2, vascular endothelial growth factor receptor 2; LHCGR, luteinizing hormone/choriogonadotropin receptor.